You can buy or sell UFPT and other stocks, options, ETFs, and crypto commission-free!
UFP Technologies, Inc. operates as a designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market. It produces products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. Read More The firm's single-use and single-patient devices and components are used in medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company was founded by Richard L. Bailly, Robert W. Drew, Sr. and William H. Shaw in 1963 and is headquartered in Newburyport, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 9
Does UFP Technologies, Inc.'s (NASDAQ:UFPT) P/E Ratio Signal A Buying Opportunity?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use UFP Technologies, Inc.'s (NASDAQ:UFPT) P/E ratio to inform your assessment of the investment opportunity. UFP Technologies has a P/E ratio of 16.81, based on the last twelve months. That means that at current prices, buyers pay $16.81 for every $1 in trailing yearly pr...
UFP Technologies (UFPT) Q1 Earnings and Revenues Beat Estimates
UFP Technologies (UFPT) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.40 per share.
UFP Technologies Announces Q1 2019 Results
NEWBURYPORT, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq:UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today reported net income of $3.7 million or $0.50 per diluted common share outstanding for its first quarter ended March 31, 2019, compared to net income of $1.8 million or $0.24 per diluted common share outstanding for the same quarter in 2018. Sales for the first quarter were $4...
Expected Aug 1, Pre-Market